| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Artemisinin | Atherosclerosis | 3 | PM | 36817159 | 📋 | Anti-malarial artesunate ameliorates atherosclerosis by modulating arterial inflammatory responses via inhibiting the NF-κB-NLRP3 inflammasome pathway |
| Artemisinin | Atherosclerosis | 1 | PM | 31895870 | 📋 | Artemisinin Attenuated Atherosclerosis in High-Fat Diet-Fed ApoE-/- Mice by Promoting Macrophage Autophagy Through the AMPK/mTOR/ULK1 Pathway |
| Artemisinin | Atherosclerosis | 2 | PM | 31094238 | 📋 | Artemisinin alleviates atherosclerotic lesion by reducing macrophage inflammation via regulation of AMPK/NF-κB/NLRP3 inflammasomes pathway |
| Artemisinin | Cardiac Arrhythmia | 1 | PM | 37161682 | 📋 | Antiarrhythmic Effect of Artemisinin in an Ex-vivo Model of Brugada Syndrome Induced by NS5806 |
| Artemisinin | Cardiac Hypertrophy | 1 | PM | 38258596 | 📋 | Artemisinin Attenuates Isoproterenol-induced Cardiac Hypertrophy via the ERK1/2 and p38 MAPK Signaling Pathways |
| Artemisinin | Cerebral Ischemia-Reperfusion | 3 | PM | 36567858 | 📋 | Artemisinin Alleviates Cerebral Ischemia/Reperfusion-Induced Oxidative Damage via Regulating PHB2-Mediated Autophagy in the Human Neuroblastoma SH-SY5Y Cell Line |
| Artemisinin | Cerebral Ischemia-Reperfusion | 2 | PM | 35950034 | 📋 | Artemisinin protects against cerebral ischemia and reperfusion injury via inhibiting the NF-κB pathway |
| Artemisinin | Cerebral Ischemia-Reperfusion | 1 | PM | 35422868 | 📋 | Artemisinin Alleviates Cerebral Ischemia/Reperfusion Injury via Regulation of the Forkhead Transcription Factor O1 Signaling Pathway |
| Artemisinin | Diabetic Cardiomyopathy | 2 | PM | 37422477 | 📋 | Artemisinin attenuates type 2 diabetic cardiomyopathy in rats through modulation of AGE-RAGE/HMGB-1 signaling pathway |
| Artemisinin | Diabetic Cardiomyopathy | 1 | PM | 37307593 | 📋 | Effect of artemisinin combined with allicin on improving cardiac function, fibrosis and NF-κB signaling pathway in rats with diabetic cardiomyopathy |
| Artemisinin | Hematologic Disorders | 1 | PM | 35293664 | 📋 | Artemisinin and l-carnitine combination therapy alters the erythrocytes redox status |
| Artemisinin | Hematologic Malignancies | 1 | PM | 33141328 | 📋 | Artemisinin-type drugs for the treatment of hematological malignancies |
| Artemisinin | Hematologic Malignancies | 2 | PM | 32048169 | 📋 | Research Progress on Artemisinin and Its Derivatives against Hematological Malignancies |
| Artemisinin | Intestinal Ischemia-Reperfusion | 1 | PM | 37441813 | 📋 | Artesunate alleviates intestinal ischemia/reperfusion induced acute lung injury via up-regulating AKT and HO-1 signal pathway in mice |
| Artemisinin | Intracerebral Hemorrhage | 2 | PM | 36815716 | 📋 | Artesunate alleviates intracerebral hemorrhage secondary injury by inducing ferroptosis in M1-polarized microglia and suppressing inflammation through AMPK/mTORC1/GPX4 pathway |
| Artemisinin | Intracerebral Hemorrhage | 1 | PM | 35349764 | 📋 | Artemisinin upregulates neural cell adhesion molecule L1 to attenuate neurological deficits after intracerebral hemorrhage in mice |
| Artemisinin | Ischemic Stroke | 1 | PM | 35864966 | 📋 | Artemisinin attenuated ischemic stroke induced cell apoptosis through activation of ERK1/2/CREB/BCL-2 signaling pathway in vitro and in vivo |
| Artemisinin | Myocardial Ischemia-Reperfusion | 1 | PM | 36034861 | 📋 | Artemisinin relieves myocardial ischemia-reperfusion injury via modulating miR-29b-3p and hemicentin 1 |
| Artemisinin | Vasoconstriction | 1 | PM | 35757500 | 📋 | Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent Models |
